# US 2012/0251464 A1 · Chalcones as enhancer of antimicrobial agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251464 A1
- Document ID: US20120251464A1
- Status: Published application
- Kind: A1
- Application number: 13/515,836
- Filed: 2009-12-18
- Published: 2012-10-04
- Earliest claimed: 2009-12-18
- Assignees: Indian Institute of Integrative Medicine; Colgate-Palmolive Complany
- Inventors: Ravi Subramanyam; Laurence Du-Thumm; Ghulam Nabi Qazi; Inshad Ali Khan; Krishan Avtar Suri; Naresh Kumar Satti; Furqan Ali; Nitin Pal Kalia
- Web page: https://patentgrep.com/patent/US20120251464A1

## CPC

- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61K 31/341: not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A61K 31/40: having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 31/04: Antibacterial agents
- C07D 207/00: Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Compounds are described that are effective in enhancing the efficacy of antimicrobial agents. Also described are methods of using such compounds and compositions that include such compounds. The composition includes a chalcone compound and, optionally, an antimicrobial agent.

## Claims

### Claim 1

A composition comprising a carrier, an antimicrobial agent and one compound selected from the group consisting of 3-(4′-Hydroxy-3′-methoxy-phenyl)-1-(2′-hydroxy-5′-methoxy-phenyl)-prop-2-ene-1-one, 3-(4′-Hydroxy-3′-methoxy-phenyl)-1-phenyl-prop-2-ene-1-one, 3 -(2″,3″-Dimethoxy-phenyl)-1-furan-2-yl-prop-2-ene-1-one, 3 -(2″,5″-dimethoxy-phenyl)-1-(1H-pyrrol-2-yl)-prop-2-ene-1-one, and mixtures thereof.

### Claim 2 (depends on 1)

The composition according to claim 1, is an oral care composition.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the antimicrobial agent comprises an antibacterial agent.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the antibacterial agent is selected from the group consisting of a quinolone, a beta lactam, a chloramphenicol, a glycopeptides, an aminoglycoside, a macrolide, a rifamycin, an oxazolidonone, a coumermycins, a polyphenolic agent, triclosan, a quaternary ammonium compound, a zinc compound, a borinic acid ester, and mixtures thereof.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the polyphenolic agent is triclosan.

### Claim 6 (depends on 4)

The composition of claim 4, wherein the polyphenolic agent comprises magnolol or its derivatives.

### Claim 7 (depends on 4)

The composition of claim 4, wherein the polyphenolic agent comprises honokiol or its derivatives.

### Claim 8 (depends on 4)

The composition of claim 4, wherein the quaternary ammonium compound is cetylpyridinium chloride.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the compound is 3-(4′-Hydroxy-3′-methoxy-phenyl)-1-phenyl-prop-2-ene-1-one.

### Claim 10 (depends on 2)

The composition of claim 2, wherein the composition is in the form of a dentifrice selected from the group consisting of toothpaste, tooth powder, gel, rinse, lozenge, chewing gum, film, and mixtures thereof.

### Claim 11 (depends on 1)

A method for treating a microbial infection comprising topically administering to a mammal in need thereof a composition as claimed in claim 1.

### Claim 12 (depends on 11)

The method according to claim 11 wherein the microbial infection is caused by a bacterium.

### Claim 13 (depends on 11)

The method according to claim 11, wherein the composition is administered to the oral cavity.

### Claim 14 (depends on 12)

The method according to claim 12, wherein the composition is in the form of a dentifrice selected from the group consisting of toothpaste, tooth powder, gel, rinse, lozenge, chewing gum, film, and mixtures thereof

### Claim 15 (depends on 11)

The method according to claim 11, wherein the antimicrobial comprises an antibacterial agent.

### Claim 16 (depends on 15)

The method of claim 15, wherein the antibacterial agent is selected from the group consisting of a quinolone, a beta lactam, a chloramphenicol, a glycopeptides, an aminoglycoside, a macrolide, a rifamycin, an oxazolidonone, a coumermycins, a polyphenolic agent, triclosan, a quaternary ammonium compound, a zinc compound, a borinic acid ester, and mixtures thereof.

### Claim 17 (depends on 16)

The method of claim 16, wherein the polyphenolic agent is triclosan.

### Claim 18 (depends on 16)

The method of claim 16, wherein the polyphenolic agent comprises magnolol or its derivatives.

### Claim 19 (depends on 16)

The method of claim 16, wherein the polyphenolic agent comprises honokiol or its derivatives.

### Claim 20 (depends on 16)

The method of claim 16, wherein the compound is 3-(4′-Hydroxy-3′-methoxy-phenyl)-1-phenyl-prop-2-ene-1-one.

### Claim 21 (depends on 11)

The method according to claim 11 wherein the microbial count is reduced.
